Skip to main content
Clinical Trials/CTRI/2014/08/004906
CTRI/2014/08/004906
Recruiting
未知

OBSERVATIONAL STUDY TO EVALUATE THE OUTCOME OF PRESCREEN FAILURE AND SCREEN FAILURE PATIENTS WHO RECEIVE CHEMORADIATON FOR LOCALLY ADVANCED HEAD AND NECK CANCER

Tata Memorial Hospital0 sites1,500 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Tata Memorial Hospital
Enrollment
1500
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Histological or cytological proven diagnosis of squamous cell or undifferentiated carcinoma of the head and neck region or squamous cell carcinoma of the head and neck region of unknown primary.
  • 2\. Planned for or has received curative intent concurrent chemoradiotherapy, either in the definitive or adjuvant setting.
  • 3\. Prescreen failure or screen failure of trial no 838/ 937

Exclusion Criteria

  • 1\. Recruited on either of below mentioned protocol:
  • i) Phase III non\-inferiority randomized trial comparing three\-weekly Cisplatin versus weekly Cisplatin in combination with radiation therapy in patients with advanced carcinoma of the head and neck( TMH NO\-937\)
  • ii) â??An Open label, Randomized, Investigator Initiated Multicentric, Phase III Study of Nimotuzumab in combination with Concurrent Radiotherapy and Cisplatin versus Radiotherapy and Cisplatin alone, in Subjects with Locally advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)â?? (TMH NO: 838\)

Outcomes

Primary Outcomes

Not specified

Similar Trials